These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 8385959
21. Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease. Morocutti A, Earle KA, Sethi M, Piras G, Pal K, Richards D, Rodemann P, Viberti G. Kidney Int; 1996 Jul; 50(1):250-6. PubMed ID: 8807595 [Abstract] [Full Text] [Related]
22. Refined estimation of kinetic parameters of the Na+/H+ antiport in human fibroblasts and platelets. Gardner JP, Tokudome G, Tomonari H, Aladjem M, Cragoe E, Aviv A. Proc Soc Exp Biol Med; 1990 Jun; 194(2):165-71. PubMed ID: 2161542 [Abstract] [Full Text] [Related]
23. Na(+)-H+ antiport activity in skin fibroblasts from blacks and whites. Hatori N, Gardner JP, Tomonari H, Fine BP, Aviv A. Hypertension; 1990 Feb; 15(2):140-5. PubMed ID: 2154402 [Abstract] [Full Text] [Related]
24. Glutathione reverses the growth abnormalities of skin fibroblasts from insulin-dependent diabetic patients with nephropathy. Morocutti A, Sethi M, Hayward A, Lee A, Viberti G. J Am Soc Nephrol; 1998 Jun; 9(6):1060-6. PubMed ID: 9621289 [Abstract] [Full Text] [Related]
25. Leukocyte intracellular pH and Na/H antiporter activity in uraemia and type I diabetes mellitus. Poli de Figueiredo CE, Ng LL, Garrido MC, Davies JE, Ellory JC, Hendry BM. Nephrol Dial Transplant; 1991 Jun; 6(9):615-20. PubMed ID: 1660575 [Abstract] [Full Text] [Related]
26. Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population. Millioni R, Puricelli L, Iori E, Trevisan R, Tessari P. Diabetes Metab Res Rev; 2012 Jan; 28(1):62-70. PubMed ID: 22218755 [Abstract] [Full Text] [Related]
27. Glucosaminyl N-deacetylase in cultured fibroblasts; comparison of patients with and without diabetic nephropathy, and identification of a possible mechanism for diabetes-induced N-deacetylase inhibition. Kofoed-Enevoldsen A, Petersen JS, Deckert T. Diabetologia; 1993 Jun; 36(6):536-40. PubMed ID: 8335176 [Abstract] [Full Text] [Related]
28. Increased platelet sodium-proton exchange rates in insulin-dependent (type 1) diabetic patients with nephropathy and hypertension. Barbe P, Salles JP, Barthe P, Louvet JP, Chap H. Mol Cell Biochem; 1992 Feb 12; 109(2):167-72. PubMed ID: 1320732 [Abstract] [Full Text] [Related]
29. Dissociation of hypertension and genetically enhanced cell growth capacity in skin fibroblasts of F2 hybrid spontaneously hypertensive rats/Wistar-Kyoto rats. Guicheney P, Soussan K, Dausse E, Rota R. Am J Hypertens; 1992 Aug 12; 5(8):556-65. PubMed ID: 1388966 [Abstract] [Full Text] [Related]
30. BSC-1 growth inhibitor transforms a mitogenic stimulus into a hypertrophic stimulus for renal proximal tubular cells: relationship to Na+/H+ antiport activity. Fine LG, Holley RW, Nasri H, Badie-Dezfooly B. Proc Natl Acad Sci U S A; 1985 Sep 12; 82(18):6163-6. PubMed ID: 2994063 [Abstract] [Full Text] [Related]
31. Granulocyte-macrophage colony-stimulating factor can stimulate macrophage proliferation via persistent activation of Na+/H+ antiport. Evidence for two distinct roles for Na+/H+ antiport activation. Vallance SJ, Downes CP, Cragoe EJ, Whetton AD. Biochem J; 1990 Jan 15; 265(2):359-64. PubMed ID: 2154185 [Abstract] [Full Text] [Related]
32. Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Davies JE, Siczkowski M, Sweeney FP, Quinn PA, Krolewski B, Krolewski AS, Ng LL. Diabetes; 1995 Apr 15; 44(4):382-8. PubMed ID: 7698504 [Abstract] [Full Text] [Related]
33. Relationships of cell proliferation and expression of integrin subunits and type I collagen in skin fibroblasts with renal lesions in patients with IDDM. Jin DK, Kim Y, Mauer M, Fioretto P, Vats A, Fish AJ. Am J Kidney Dis; 1998 Feb 15; 31(2):293-300. PubMed ID: 9469500 [Abstract] [Full Text] [Related]
34. Na/H and Li/Na exchange in red blood cells of normotensive and hypertensive patients with insulin dependent diabetes mellitus (IDDM). Semplicini A, Mozzato MG, Sama' B, Nosadini R, Fioretto P, Trevisan R, Pessina AC, Crepaldi G, Dal Palu' C. Am J Hypertens; 1989 Mar 15; 2(3 Pt 1):174-7. PubMed ID: 2537645 [Abstract] [Full Text] [Related]
35. Abnormalities in Na+/H+ antiporter activity in diabetic nephropathy. Ng LL, Davies JE. J Am Soc Nephrol; 1992 Oct 15; 3(4 Suppl):S50-5. PubMed ID: 1333834 [Abstract] [Full Text] [Related]
36. Intracellular pH regulation of SV-40 virus transformed human MRC-5 fibroblasts and cell membrane cholesterol. Ng LL, Delva P, Davies JE. Am J Physiol; 1993 Apr 15; 264(4 Pt 1):C789-93. PubMed ID: 8386450 [Abstract] [Full Text] [Related]
37. Low Ca(2+) pump activity in diabetic nephropathy. Podestá F, Meregalli G, Ghelardi R, Del Giudice R, Asnaghi V, Maestroni A, Zerbini G. Am J Kidney Dis; 2001 Sep 15; 38(3):465-72. PubMed ID: 11532676 [Abstract] [Full Text] [Related]
38. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy. Andersen H, Hansen PB, Bistrup C, Nielsen F, Henriksen JE, Jensen BL. J Hypertens; 2016 Aug 15; 34(8):1621-9. PubMed ID: 27214087 [Abstract] [Full Text] [Related]
39. Na-H antiport in cultured rat aortic smooth muscle: its role in cytoplasmic pH regulation. Weissberg PL, Little PJ, Cragoe EJ, Bobik A. Am J Physiol; 1987 Aug 15; 253(2 Pt 1):C193-8. PubMed ID: 3039852 [Abstract] [Full Text] [Related]
40. [Diabetic nephropathy. I. Pathomorphology and pathogenesis]. Matuszkiewicz-Rowińska J, Ostrowski K. Pol Arch Med Wewn; 1992 Jul 15; 88(1):57-61. PubMed ID: 1454661 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]